2 of the counters that I am monitoring has a bullish gap.
1. 3PAR (PAR) has a bullish gap on speculation that it will be acquired.
2. Sinovac Biotech (SVA) files for a new vaccination on trials for hand, foot, mouth disease.
2 of the counters that I am monitoring has a bullish gap.
1. 3PAR (PAR) has a bullish gap on speculation that it will be acquired.
2. Sinovac Biotech (SVA) files for a new vaccination on trials for hand, foot, mouth disease.
Yesterday, SVA tested support at 6.30 and managed to close below it at 6.28
At this moment, the bearish trend will continue. There is no confirmation of any reversal .
We may see SVA drift further down.
Next support based on the Chikou Span is
- 5.85 (Support 1)
- 5.10 (Support 2)
Got this from InvestIdeas forum.
A member highlighted an article
Chinese government support and ‘sea turtles’ are spurring the sector, but investors lack exits.
The key point highlighted in the article includes a claim that investors may lack an exit strategy despite the huge potential of the biotecfh market in China.
The article can be found here.